Symmetrical polyneuropathy in coronavirus disease 2019 (COVID-19)

Fereshteh Ghiasvand; Maryam Ghadimi; Fatemeh Ghadimi; Samin Safarpour; Roghieh Hosseinzadeh; SeyedAhmad SeyedAlinaghi

doi:10.1016/j.idcr.2020.e00815

Symmetrical polyneuropathy in coronavirus disease 2019 (COVID-19)

IDCases. 2020 May 15:21:e00815. doi: 10.1016/j.idcr.2020.e00815. eCollection 2020.

Authors

Fereshteh Ghiasvand¹, Maryam Ghadimi², Fatemeh Ghadimi³, Samin Safarpour¹, Roghieh Hosseinzadeh¹, SeyedAhmad SeyedAlinaghi³

Affiliations

¹ Department of Infectious Diseases, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
² Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
³ Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran.

Abstract

The outbreak of the novel coronavirus that began in late December 2019 was announced as a pandemic by the World Health Organization as the number of cases is increasing exponentially throughout the globe. We presented a patient with confirmed SARS-CoV-2 pneumonia developing symmetric polyneuropathy. To our knowledge, extrapulmonary clinical presentations of 2019 novel coronavirus disease (COVID-19) have rarely been reported. This case highlights the possible association between SARS-CoV-2 infection and nervous system involvement.

Keywords: COVID-19; Nervous system; Pneumonia; Polyneuropathy; SARS-CoV-2.

Publication types

Case Reports